In last trading session, Pacific Biosciences of California Inc (NASDAQ:PACB) saw 11.83 million shares changing hands with its beta currently measuring 2.13. Company’s recent per share price level of $1.22 trading at $0.02 or 1.67% at ring of the bell on the day assigns it a market valuation of $366.10M. That closing price of PACB’s stock is at a discount of -122.95% from its 52-week high price of $2.72 and is indicating a premium of 30.33% from its 52-week low price of $0.85.
For Pacific Biosciences of California Inc (PACB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.21. Splitting up the data highlights that, out of 11 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 4 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Pacific Biosciences of California Inc (NASDAQ:PACB) trade information
Upright in the green during last session for gaining 1.67%, in the last five days PACB remained trading in the red while hitting it’s week-highest on Friday, 06/20/25 when the stock touched $1.22 price level, adding 8.96% to its value on the day. Pacific Biosciences of California Inc’s shares saw a change of -17.01% in year-to-date performance and have moved -6.15% in past 5-day. Pacific Biosciences of California Inc (NASDAQ:PACB) showed a performance of 32.35% in past 30-days.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 59.33% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 4. It follows that stock’s current price would drop -63.93% in reaching the projected high whereas dropping to the targeted low would mean a loss of -63.93% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -23.55% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 6.94% while estimates for its earnings growth in next 5 years are of 27.48%.
Pacific Biosciences of California Inc (NASDAQ:PACB)’s Major holders
ARK INVESTMENT MANAGEMENT LLC is the top institutional holder at PACB for having 33.21 million shares of worth $45.5 million. And as of 2024-06-30, it was holding 12.1932 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 26.0 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.5449 of outstanding shares, having a total worth of $35.62 million.
